Evidence map›Paper›PMID 40604858›Full record

ArticleBMC oral health2025

Clinical and histological indicators for malignant transformation of oral submucous fibrosis: an analysis of cases from a tertiary care center.

Vedaa Naik, Mathangi Kumar, Monica Charlotte Solomon, Chetana Chandrashekhar, Vasudeva Guddattu

Abstract read
In one paragraph

Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vedaa NaikManipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, 576104, Manipal, Karnataka, India.
Mathangi KumarDepartment of Oral Medicine & Radiology, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, 576104, Manipal, Karnataka, India. mathangi.kumar@manipal.edu.
Monica Charlotte SolomonDepartment of Oral and Maxillofacial Pathology and Oral Microbiology, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, 576104, Manipal, Karnataka, India. monica.charlotte@manipal.edu.
Chetana ChandrashekharDepartment of Oral and Maxillofacial Pathology and Oral Microbiology, Manipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, 576104, Manipal, Karnataka, India.
Vasudeva GuddattuDepartment of Applied Statistics and Data Science of Public Health, Prassana School of Public Health, Manipal Academy of Higher Education, 576104, Manipal, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral submucous fibrosis (OSMF), a potentially malignant disorder predominantly affecting South Asian populations, is characterized by irreversible progression and significant malignant transformation potential. Early identification of risk indicators is crucial for implementing preventive measures and appropriate interventions to curb disease progression. While clinical parameters and histological features have been studied independently, comprehensive analyses evaluating multiple clinical manifestations, histopathological characteristics, and their correlations remain limited, particularly in long-term studies. This study aimed to assess individual clinical and histological parameters, and evaluate their relationships to identify early indicators of malignant transformation, thereby enabling more effective early intervention strategies.

methodsA retrospective analysis of electronic records from January 2012 to July 2024 was conducted on 118 OSMF patients aged 20-70 years, excluding those with concurrent mucosal lesions or incomplete records. Clinical parameters, including fibrous bands, burning sensation, mouth opening (measured by Vernier caliper), ulceration, and mucosal blanching, were graded based on Haider's classification, while histopathological features such as epithelial thickness, keratinization, blood vessel characteristics, signet ring cells, inflammatory infiltration, and hyalinization were graded according to Pindborg and Sirsat's classification. Data analysis was performed using Jamovi Software, employing descriptive statistics and chi-square tests to assess categorical data, with statistical significance set at p < 0.05.

resultsAmong 118 OSMF patients (89.8% males, mean age 41 years), buccal mucosa was predominantly affected (93%). Major clinical features included burning sensation (87.3%), blanching (95.8%), and fibrous bands (96.6%). Of 106 patients, 41.5% showed Stage 1 mouth opening (> 20 mm), with 60% of malignant transformations occurring in this group. Histopathologically, 49.2% cases were moderately advanced, showing atrophic epithelium (56%), keratinization (85.6%), and juxta-epithelial hyalinization (92.4%). The study revealed a 4.2% malignant transformation rate, with epithelial dysplasia observed in 27% cases.

conclusionsThe study highlights the significance of early diagnosis, as even in the initial stages of OSMF (mouth opening < 20 mm, grade 1), there were advanced histological changes that were observed along with a risk of malignant transformation. The observed rate of malignant transformation was 4.2% and hence prompt identification of the clinical and histological indicators for malignant transformation can help in improving patient outcomes.

Indexed as

Cell Transformation, NeoplasticMouth NeoplasmsOral Submucous FibrosisAdultAgedFemaleHumansMaleMiddle AgedMouth MucosaRetrospective StudiesTertiary Care CentersYoung AdultHistopathologyMalignant transformationOral submucous fibrosisPotentially malignant oral disorders

Identifiers

PMID40604858
PMCPMC12225352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.